Statistics for Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children
Total visits
| views | |
|---|---|
| Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children | 2 |
Total visits per month
| views | |
|---|---|
| octubre 2024 | 0 |
| noviembre 2024 | 0 |
| diciembre 2024 | 0 |
| enero 2025 | 0 |
| febrero 2025 | 0 |
| marzo 2025 | 0 |
| abril 2025 | 0 |
File Visits
| views | |
|---|---|
| Cochrane.png | 4 |